Krystal Biotech, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Krystal Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2024.
  • Krystal Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was $45.5M, a 423% increase year-over-year.
  • Krystal Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $89.2M, a 716% increase year-over-year.
  • Krystal Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $89.2M, a 716% increase from 2023.
  • Krystal Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $10.9M.
  • Krystal Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$140M, a 101% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $89.2M +$78.2M +716% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-19
2023 $10.9M +$151M Jan 1, 2023 Dec 31, 2023 10-K 2025-02-19
2022 -$140M -$70.4M -101% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-19
2021 -$69.6M -$37.4M -116% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$32.2M -$13.1M -68.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$19.1M -$8.2M -75.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$10.9M -$2.97M -37.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 -$7.92M -$6.77M -589% Jan 1, 2017 Dec 31, 2017 10-K 2018-03-12
2016 -$1.15M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.